Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Multicentric, national, prospective, parallel group, controlled. The Subjects in every center
will be randomized and assigned to the pharmacologic arm or the one with the biochemical
monitoring